1. Home
  2. MYGN vs VECO Comparison

MYGN vs VECO Comparison

Compare MYGN & VECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$6.13

Market Cap

625.5M

Sector

Health Care

ML Signal

HOLD

Logo Veeco Instruments Inc.

VECO

Veeco Instruments Inc.

HOLD

Current Price

$28.53

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
VECO
Founded
1991
1945
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
625.5M
1.9B
IPO Year
1995
1994

Fundamental Metrics

Financial Performance
Metric
MYGN
VECO
Price
$6.13
$28.53
Analyst Decision
Buy
Buy
Analyst Count
12
6
Target Price
$11.82
$28.00
AVG Volume (30 Days)
874.1K
591.0K
Earning Date
11-03-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.83
Revenue
$825,300,000.00
$681,408,000.00
Revenue This Year
$0.08
N/A
Revenue Next Year
$5.28
$9.65
P/E Ratio
N/A
$34.40
Revenue Growth
0.21
N/A
52 Week Low
$3.76
$16.92
52 Week High
$15.47
$34.45

Technical Indicators

Market Signals
Indicator
MYGN
VECO
Relative Strength Index (RSI) 34.00 39.20
Support Level $6.38 $28.90
Resistance Level $6.89 $29.58
Average True Range (ATR) 0.27 1.02
MACD -0.08 -0.22
Stochastic Oscillator 1.13 3.43

Price Performance

Historical Comparison
MYGN
VECO

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.

Share on Social Networks: